Crop protection's reset: FMC reprices the channel as Corteva fights in court

Two filings this week put the crop-protection industry back in focus. FMC slashed its third-quarter outlook to reprice products sitting in distributor warehouses, and Corteva disclosed that a multistate lawsuit over its newly completed separation has produced a court order restricting capital returns. One is a pricing problem and the other a legal one, but both land on the same theme: the economics of branded crop chemicals are under pressure.

FMC: taking the hit up front

FMC now expects third-quarter revenue of $65 million to $125 million and adjusted EBITDA of negative $565 million to negative $510 million. In July it had guided to $840 million to $900 million of revenue excluding India and $120 million to $140 million of adjusted EBITDA. The difference is mostly deliberate: the estimates include a $625 million to $675 million impact from commercial actions, chiefly cutting prices on products already held by channel customers in Brazil, Argentina, the U.S. and Canada, and narrowing the gap between gross and net pricing in the U.S., where the company has historically paired high list prices with high rebates.

FMC said "third-quarter demand was weaker than we expected," and the company pointed to rapid price declines, partly from increased generic competition, that widened the gap between the value of channel inventory and current market prices. FMC also said distributors are running their lowest inventory levels in its history. In its July release, the company had already reported second-quarter revenue of $867.1 million, down from $1,050.5 million a year earlier, and expected full-year price to be lower by mid-to-high single digits.

The balance sheet is the pressure point. FMC said a triggering event for intangible impairment testing occurred as of Sept. 30 and that it may record a material non-cash charge. It expects to comply with covenants at quarter-end but plans to talk with its bank group about further covenant modifications over the next year. Total debt was $4.28 billion at June 30.

Corteva: the split is done, the payout is frozen

Corteva completed its separation from Vylor on Oct. 1, the same day 15 states and one sovereign sued in federal court in Indiana to challenge it. On Oct. 9 the court issued a temporary restraining order barring the companies from paying dividends, repurchasing stock or disposing of assets outside the ordinary course. The court stayed that order on Oct. 10 pending an emergency motion at the Seventh Circuit, relying on Corteva's representation that it does not intend to declare dividends or repurchase shares while the motion is pending. Corteva said it strongly contests the claims.

The AlphaGen read

FMC's reset reads as a company choosing one very bad quarter over several mediocre ones, and cleaner channel pricing could make future results easier to read. The risk is that the impairment and covenant talks crystallize just as generic pressure persists. For Corteva, the separation itself is not unwound, but shareholders face an uncertain wait on capital returns. FMC's Oct. 29 results and Oct. 30 call, where it plans to share preliminary 2027 and 2028 expectations, are the next checkpoints.